+1 (646) 663-5829 | +91 702 496 8807

  sales@regionalresearchreports.com

Neurodegenerative Drugs Market Size, Share, and COVID-19 Impact Analysis by Drug Class, Indication, Distribution Channel, Regions, Company Market Share, and Regional Forecast, 2022-2030

Publish Date: Jan 2025
Report ID:HC-8823
Base Year:2024
Report Format:PDF, Excel
Report Pages:182
Region:Global

  1. Global Neurodegenerative Drugs Market Introduction and Market Overview
    1. Objective of the Study
    2. Global Neurodegenerative Drugs Market Scope and Market Estimation
      1. Global Neurodegenerative Drugs Market Overall Market Size (US$ Mn), Market CAGR (%), Market Forecast (2023-2033)
      2. Global Neurodegenerative Drugs Market Revenue Share (%) and Growth Rate (Y-o-Y) from 2018-2033
    3. Market Segmentation
      1. Drug Class of Global Neurodegenerative Drugs Market
      2. Indication of Global Neurodegenerative Drugs Market
      3. Distribution Channel of Global Neurodegenerative Drugs Market
      4. Region of Global Neurodegenerative Drugs Market
  2. Global Neurodegenerative Drugs Market - Executive Summary
    1. Key Findings
      1. Top Impacting Factors
      2. Top Investment Pockets         
      3. Market Attractiveness Analysis         
    2. Key Companies Introduction
  3. Market Factor Analysis
    1. Global Neurodegenerative Drugs Market Industry Development Trends under COVID-19 Outbreak
      1. Global COVID-19 Status Overview
      2. Influence of COVID-19 Outbreak on Global Neurodegenerative Drugs Market Industry Development
    2. Market Dynamics (Growth Influencers)
      1. Drivers
      2. Restraints
      3. Opportunities
      4. Impact Analysis of Drivers and Restraints
    3. Ecosystem/ Value Chain Analysis
    4. Porter’s Five Forces Analysis
    5. SWOT Analysis
    6. PEST Analysis
    7. Market Opportunity Assessment – by Region (North America/ Europe/ Asia Pacific/ Middle East and Africa/ South America)
      1. By Drug Class
      2. By Indication
      3. By Distribution Channel
  4. Global Neurodegenerative Drugs Market: Estimates and Historic Trend Analysis (2018-2021)
  5. Global Neurodegenerative Drugs Market Estimates and Forecast Trend Analysis, by Drug Class
    1. Neurodegenerative Drugs Market Share (%) Estimates and Forecasts, by Drug Class, 2022, 2023 and 2033
      1. Key Market Trends, Growth Factors, and Opportunities
    2. Neurodegenerative Drugs Market Revenue (US$ Mn) Estimates and Forecasts, by Drug Class, 2023 to 2033
      1. Key Market Trends, Growth Factors, and Opportunities
    3. Dopamine agonist
    4. Decarboxylase inhibitors
    5. Cholinesterase Inhibitors
    6. Immunomodulators
    7. Others
  6. Global Neurodegenerative Drugs Market Estimates and Forecast Trend Analysis, by Indication
    1. Neurodegenerative Drugs Market Share (%) Estimates and Forecasts, by Indication, 2022, 2023 and 2033
      1. Key Market Trends, Growth Factors, and Opportunities
    2. Neurodegenerative Drugs Market Revenue (US$ Mn) Estimates and Forecasts, by Indication, 2023 to 2033
      1. Key Market Trends, Growth Factors, and Opportunities
    3. Parkinson’s Disease
    4. Alzheimer’s Disease
    5. Multiple Sclerosis
    6. Others
  7. Global Neurodegenerative Drugs Market Estimates and Forecast Trend Analysis, by Distribution Channel
    1. Neurodegenerative Drugs Market Share (%) Estimates and Forecasts, by Distribution Channel, 2022, 2023 and 2033
      1. Key Market Trends, Growth Factors, and Opportunities
    2. Neurodegenerative Drugs Market Revenue (US$ Mn) Estimates and Forecasts, by Distribution Channel, 2023 to 2033
      1. Key Market Trends, Growth Factors, and Opportunities
    3. Hospital Pharmacies
    4. Online Providers
    5. Drug Stores and Retail Pharmacies
  8. Global Neurodegenerative Drugs Market Analysis and Forecast, by Region
    1. Neurodegenerative Drugs Market Share (%) Estimates and Forecasts, by Region, 2022, 2023 and 2033
      1. Key Market Trends, Growth Factors, and Opportunities
    2. Neurodegenerative Drugs Market Revenue (US$ Mn) Estimates and Forecasts, by Region, 2023 to 2033
      1. Key Market Trends, Growth Factors, and Opportunities
      2. North America
      3. Europe
      4. Asia Pacific
      5. Middle East and Africa
      6. South America
  9. North America Neurodegenerative Drugs Market: Estimates and Forecast Trend Analysis
    1. North America Market Assessments and Key Findings
    2. North America Neurodegenerative Drugs Market Share (%) Estimates and Forecasts, 2022, 2023 and 2033
    3. North America Neurodegenerative Drugs Market Size Estimates and Forecast (US$ Million) (2023 to 2033)
      1. By Drug Class
      2. By Indication
      3. By Distribution Channel
      4. By Country
        1. U.S.
        2. Canada
        3. Mexico
  10. Europe Neurodegenerative Drugs Market: Estimates and Forecast Trend Analysis
    1. Europe Market Assessments and Key Findings
    2. Europe Neurodegenerative Drugs Market Share (%) Estimates and Forecasts, 2022, 2023 and 2033
    3. Europe Neurodegenerative Drugs Market Size Estimates and Forecast (US$ Million) (2023 to 2033)
      1. By Drug Class
      2. By Indication
      3. By Distribution Channel
      4. By Country
        1. Germany
        2. U.K.
        3. France
        4. Italy
        5. Spain
        6. Russia
        7. Rest of Europe
  11. Asia Pacific Neurodegenerative Drugs Market: Estimates and Forecast Trend Analysis
    1. Asia Pacific Market Assessments and Key Findings
    2. Asia Pacific Neurodegenerative Drugs Market Share (%) Estimates and Forecasts, 2022, 2023 and 2033
    3. Asia Pacific Market Size Estimates and Forecast (US$ Million) (2023 to 2033)
      1. By Drug Class
      2. By Indication
      3. By Distribution Channel
      4. By Country
        1. China
        2. Japan
        3. India
        4. Australia
        5. South Korea
        6. Rest of Asia Pacific
  12. Middle East and Africa Neurodegenerative Drugs Market: Estimates and Forecast Trend Analysis
    1. Middle East and Africa Market Assessments and Key Findings
    2. Middle East and Africa Neurodegenerative Drugs Market Share (%) Estimates and Forecasts, 2022, 2023 and 2033
    3. Middle East and Africa Market Size Estimates and Forecast (US$ Million) (2023 to 2033)
      1. By Drug Class
      2. By Indication
      3. By Distribution Channel
      4. By Country
        1. U.A.E.
        2. Saudi Arabia
        3. Egypt
        4. South Africa
        5. Rest of Middle East and Africa
  13. South America Neurodegenerative Drugs Market: Estimates and Forecast Trend Analysis
    1. South America Market Assessments and Key Findings
    2. South America Neurodegenerative Drugs Market Share (%) Estimates and Forecasts, 2022, 2023 and 2033
    3. South America Market Size Estimates and Forecast (US$ Million) (2023 to 2033)
      1. By Drug Class
      2. By Indication
      3. By Distribution Channel
      4. By Country
        1. Brazil
        2. Argentina
        3. Colombia
        4. Rest of South America
  14. Manufacturing Cost Structure Analysis
    1. Raw Material and Suppliers
    2. Manufacturing Cost Structure Analysis of Neurodegenerative Drugs Market
    3. Manufacturing Process Analysis of Neurodegenerative Drugs Market
    4. Industry Chain Structure of Neurodegenerative Drugs Market
  15. Marketing, Distributors and Customer
    1. Sales Channel
      1. Direct Channels
      2. Indirect Channels
    2. Neurodegenerative Drugs Market Distributors
    3. Neurodegenerative Drugs Market Customer
  16. Competition Landscape
    1. Key Manufacturers Neurodegenerative Drugs Market Producing Area Distribution, Sales Area, Product
    2. Key Manufacturers Neurodegenerative Drugs Market Product Location Distribution
    3. Market Competition Matrix, by Leading Players
      1. Competition Landscape Analysis
      2. Concentration Ratio (CR3, CR5 and CR10) and (2020-2022)
    4. List of Emerging, Prominent and Leading Players
    5. Major Mergers and Acquisitions, Partnership, Joint Venture, Expansions, Deals, Etc.
  17. Company Profiles
    1. F. Hoffmann-La Roche Ltd.
      1.  Company Overview
      2. Financial Performance (2018-2022, USD Million)
      3.  Geographical Footprint Analysis
      4. Product Portfolio - Product Category, Type, and Specification
      5. Product Suppliers and Distributors
      6. Key Recent Development (2018-2023)
      7.  Top Wining Strategies
      8. Partnerships/Collaboration/Merger/Acquisition/Expansion/Others
      9. SWOT Analysis
      10.  Strategic Initiatives
    2. Teva Pharmaceutical Industries Ltd.
      1. Company Overview
      2.  Financial Performance (2018-2022, USD Million)
      3.  Geographical Footprint Analysis
      4.  Product Portfolio - Product Category, Type, and Specification
      5.  Product Suppliers and Distributors
      6.  Key Recent Development (2018-2023)
      7.  Top Wining Strategies
      8.  Partnerships/Collaboration/Merger/Acquisition/Expansion/Others
      9.  SWOT Analysis
      10.  Strategic Initiatives
    3. Sun Pharmaceutical Industries Ltd.
      1.  Company Overview
      2.  Financial Performance (2018-2022, USD Million)
      3.  Geographical Footprint Analysis
      4.  Product Portfolio - Product Category, Type, and Specification
      5.  Product Suppliers and Distributors
      6.  Key Recent Development (2018-2023)
      7.  Top Wining Strategies
      8.  Partnerships/Collaboration/Merger/Acquisition/Expansion/Others
      9.  SWOT Analysis
      10.  Strategic Initiatives
    4. Orion Corporation
      1. Company Overview
      2.  Financial Performance (2018-2022, USD Million)
      3.  Geographical Footprint Analysis
      4.  Product Portfolio - Product Category, Type, and Specification
      5.  Product Suppliers and Distributors
      6.  Key Recent Development (2018-2023)
      7.  Top Wining Strategies
      8.  Partnerships/Collaboration/Merger/Acquisition/Expansion/Others
      9.  SWOT Analysis
      10.  Strategic Initiatives
    5. Biogen
      1. Company Overview
      2.  Financial Performance (2018-2022, USD Million)
      3.  Geographical Footprint Analysis
      4.  Product Portfolio - Product Category, Type, and Specification
      5.  Product Suppliers and Distributors
      6.  Key Recent Development (2018-2023)
      7.  Top Wining Strategies
      8.  Partnerships/Collaboration/Merger/Acquisition/Expansion/Others
      9.  SWOT Analysis
      10.  Strategic Initiatives
    6. Sanofi
      1. Company Overview
      2.  Financial Performance (2018-2022, USD Million)
      3.  Geographical Footprint Analysis
      4.  Product Portfolio - Product Category, Type, and Specification
      5.  Product Suppliers and Distributors
      6.  Key Recent Development (2018-2023)
      7.  Top Wining Strategies
      8.  Partnerships/Collaboration/Merger/Acquisition/Expansion/Others
      9.  SWOT Analysis
      10.  Strategic Initiatives
    7. Viatris Inc.
      1.  Company Overview
      2.  Financial Performance (2018-2022, USD Million)
      3.  Geographical Footprint Analysis
      4.  Product Portfolio - Product Category, Type, and Specification
      5.  Product Suppliers and Distributors
      6.  Key Recent Development (2018-2023)
      7.  Top Wining Strategies
      8.  Partnerships/Collaboration/Merger/Acquisition/Expansion/Others
      9.  SWOT Analysis
      10.  Strategic Initiatives
    8. Novartis AG
      1. Company Overview
      2.  Financial Performance (2018-2022, USD Million)
      3.  Geographical Footprint Analysis
      4.  Product Portfolio - Product Category, Type, and Specification
      5.  Product Suppliers and Distributors
      6.  Key Recent Development (2018-2023)
      7.  Top Wining Strategies
      8.  Partnerships/Collaboration/Merger/Acquisition/Expansion/Others
      9.  SWOT Analysis
      10.  Strategic Initiatives
    9. UCB S.A.
      1. Company Overview
      2.  Financial Performance (2018-2022, USD Million)
      3.  Geographical Footprint Analysis
      4.  Product Portfolio - Product Category, Type, and Specification
      5.  Product Suppliers and Distributors
      6.  Key Recent Development (2018-2023)
      7.  Top Wining Strategies
      8.  Partnerships/Collaboration/Merger/Acquisition/Expansion/Others
      9.  SWOT Analysis
      10.  Strategic Initiatives
    10. AbbVie Inc
      1.  Company Overview
      2.  Financial Performance (2018-2022, USD Million)
      3.  Geographical Footprint Analysis
      4.  Product Portfolio - Product Category, Type, and Specification
      5.  Product Suppliers and Distributors
      6.  Key Recent Development (2018-2023)
      7.  Top Wining Strategies
      8.  Partnerships/Collaboration/Merger/Acquisition/Expansion/Others
      9.  SWOT Analysis
      10.  Strategic Initiatives
  18. Assumptions and Research Methodology
  19. Conclusions and Recommendations
    1. Analysis and Suggestions on New Project Investment
    2. Research Findings and Conclusion
  1. Global Neurodegenerative Drugs Market Historic Analysis (US$ Mn), 2018-2022
  2. Global Neurodegenerative Drugs Market Forecast Opportunity Analysis (US$ Mn), 2023-2033
  3. Global Neurodegenerative Drugs Market Absolute $ Opportunity
  4. Global Neurodegenerative Drugs Market Analysis by Drug Class, 2023-2033
  5. Global Neurodegenerative Drugs Market Analysis by Indication, 2023-2033
  6. Global Neurodegenerative Drugs Market Analysis by Distribution Channel, 2023-2033
  7. Global Neurodegenerative Drugs Market Analysis by Region, 2023-2033
  8. North America Neurodegenerative Drugs Market Absolute $ Opportunity
  9. North America Neurodegenerative Drugs Market Analysis by Drug Class, 2023-2033
  10. North America Neurodegenerative Drugs Market Analysis by Indication, 2023-2033
  11. North America Neurodegenerative Drugs Market Analysis by Distribution Channel, 2023-2033
  12. North America Neurodegenerative Drugs Market Analysis by Country, 2023-2033
  13. South America Neurodegenerative Drugs Market Absolute $ Opportunity
  14. South America Neurodegenerative Drugs Market Analysis by Drug Class, 2023-2033
  15. South America Neurodegenerative Drugs Market Analysis by Indication, 2023-2033
  16. South America Neurodegenerative Drugs Market Analysis by Distribution Channel, 2023-2033
  17. South America Neurodegenerative Drugs Market Analysis by Country, 2023-2033
  18. Europe Neurodegenerative Drugs Market Absolute $ Opportunity
  19. Europe Neurodegenerative Drugs Market Analysis by Drug Class, 2023-2033
  20. Europe Neurodegenerative Drugs Market Analysis by Indication, 2023-2033
  21. Europe Neurodegenerative Drugs Market Analysis by Distribution Channel, 2023-2033
  22. Europe Neurodegenerative Drugs Market Analysis by Country, 2023-2033
  23. Asia Pacific Neurodegenerative Drugs Market Absolute $ Opportunity
  24. Asia Pacific Neurodegenerative Drugs Market Analysis by Drug Class, 2023-2033
  25. Asia Pacific Neurodegenerative Drugs Market Analysis by Indication, 2023-2033
  26. Asia Pacific Neurodegenerative Drugs Market Analysis by Distribution Channel, 2023-2033
  27. Asia Pacific Neurodegenerative Drugs Market Analysis by Country, 2023-2033
  28. MEA Neurodegenerative Drugs Market Absolute $ Opportunity
  29. MEA Neurodegenerative Drugs Market Analysis by Drug Class, 2023-2033
  30. MEA Neurodegenerative Drugs Market Analysis by Indication, 2023-2033
  31. MEA Neurodegenerative Drugs Market Analysis by Distribution Channel, 2023-2033
  32. MEA Neurodegenerative Drugs Market Analysis by Country, 2023-2033

List of Figures

  1. Global Neurodegenerative Drugs Market Historic Y-o-Y Analysis (%), 2018-2022
  2. Global Neurodegenerative Drugs Market Forecast Y-o-Y Analysis (%), 2023-2033
  3. Global Neurodegenerative Drugs Market Share Analysis by Drug Class, 2022, 2023, and 2033
  4. Global Neurodegenerative Drugs Market Share Analysis by Indication, 2022, 2023, and 2033
  5. Global Neurodegenerative Drugs Market Share Analysis by Distribution Channel, 2022, 2023, and 2033
  6. Global Neurodegenerative Drugs Market Share Analysis by Region, 2022, 2023, and 2033
  7. North America Neurodegenerative Drugs Market Share Analysis by Drug Class, 2022, 2023, and 2033
  8. North America Neurodegenerative Drugs Market Share Analysis by Indication, 2022, 2023, and 2033
  9. North America Neurodegenerative Drugs Market Share Analysis by Distribution Channel, 2022, 2023, and 2033
  10. North America Neurodegenerative Drugs Market Share Analysis by Country, 2022, 2023, and 2033
  11. South America Neurodegenerative Drugs Market Share Analysis by Drug Class, 2022, 2023, and 2033
  12. South America Neurodegenerative Drugs Market Share Analysis by Indication, 2022, 2023, and 2033
  13. South America Neurodegenerative Drugs Market Share Analysis by Distribution Channel, 2022, 2023, and 2033
  14. South America Neurodegenerative Drugs Market Share Analysis by Country, 2022, 2023, and 2033
  15. Europe Neurodegenerative Drugs Market Share Analysis by Drug Class, 2022, 2023, and 2033
  16. Europe Neurodegenerative Drugs Market Share Analysis by Indication, 2022, 2023, and 2033
  17. Europe Neurodegenerative Drugs Market Share Analysis by Distribution Channel, 2022, 2023, and 2033
  18. Europe Neurodegenerative Drugs Market Share Analysis by Country, 2022, 2023, and 2033
  19. Asia Pacific Neurodegenerative Drugs Market Share Analysis by Drug Class, 2022, 2023, and 2033
  20. Asia Pacific Neurodegenerative Drugs Market Share Analysis by Indication, 2022, 2023, and 2033
  21. Asia Pacific Neurodegenerative Drugs Market Share Analysis by Distribution Channel, 2022, 2023, and 2033
  22. Asia Pacific Neurodegenerative Drugs Market Share Analysis by Country, 2022, 2023, and 2033
  23. MEA Neurodegenerative Drugs Market Share Analysis by Drug Class, 2022, 2023, and 2033
  24. MEA Neurodegenerative Drugs Market Share Analysis by Indication, 2022, 2023, and 2033
  25. MEA Neurodegenerative Drugs Market Share Analysis by Distribution Channel, 2022, 2023, and 2033
  26. MEA Neurodegenerative Drugs Market Share Analysis by Country, 2022, 2023, and 2033
market statsville report image

Want to Review Complete Market Research Report

Request Sample
$3150  $2950 save 23%
$4950  $3250 save 25%
$7680  $4450 save 30%
Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Budget constrains? Get in touch with us for special pricing
Request Discount

Phone: +1 (888) 615 4898

Email: sales@regionalresearchreports.com

Chat with Us: Click here to start